120 results on '"Kim, S.T."'
Search Results
2. Evaluating Mid-Term Outcomes of COVID-19 Donor Heart Transplantation in the United States
3. Characterizing the Impact of Donor Sequence Number on Outcomes Following Heart Transplantation
4. Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer
5. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
6. (273) Postoperative Renal Failure in Patients Undergoing Isolated Heart Transplantation: What are the Outcomes?
7. Lung Transplantation from HCV NAT+ Donors: Reassuring Mid-Term Outcomes
8. (256) Ex-Vivo Lung Perfusion May Have a Detrimental Impact on Lung Transplants from Donation after Circulatory Death Donors
9. (405) Predictors and Outcomes of Post-Operative Extracorporeal Membrane Oxygenation at 72 Hours Following Lung Transplantation
10. (59) Mid-Term Outcomes of Heart Transplants from HCV NAT+ Donors
11. (70) Normothermic Regional Perfusion in Donation after Circulatory Death Heart Donors May Not Have a Detrimental Effect on Lung Transplant Outcomes
12. Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A
13. A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer
14. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy
15. Core clinical symptoms and suicidal ideation in patients with obsessive compulsive disorder – a network analysis
16. 1379P Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+ 1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A
17. 529P A phase Ib trial of belvarafenib in combination with cobimetinib in patients (pts) with RAS- or RAF- mutated (m) solid tumors: Updated safety data and indication-specific efficacy results
18. 1048P Baseline and post-treatment biomarkers of resistance to anti-PD-1 (aPD1) therapy in acral and mucosal melanoma
19. Impact of Frailty on Acute Outcomes of Endovascular Thoracic and Abdominal Aneurysm Repair
20. PREDICTORS FOR SUCCESS OF INTRAUTERINE INSEMINATION: A RETROSPECTIVE ANALYSIS
21. Impact of Donor Sequence Number on Survival Following Heart Transplantation
22. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆
23. Molecular profiling of Asian patients with advanced melanoma receiving check-point inhibitor treatment
24. A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy
25. Pregnancy rate of intrauterine insemination (IUI) - is it affected by inseminated motile sperm count and stimulation protocol?
26. Clinical usefulness of tumor mutational burden (TMB) assessed by NGS in solid tumors
27. 69P PD-L1 expression as a prognostic marker in patients with advanced biliary tract cancer
28. A randomized controlled trial of botulinum toxin for treating sleep bruxism: a polysomnographic evaluation
29. Next-generation sequencing for better treatment strategy of cancer of unknown primary (CUP)
30. P1.01-97 Modified RANO-LM Criteria to Evaluate the Radiological Response of Osimertinib in EGFR T790M Positive NSCLC with Leptomeningeal Metastases
31. PCV68 EFFECTS OF COCAINE ON THE CARDIOVASCULAR SYSTEM IN HUMANS
32. Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
33. Adapting the MgO-CO2 working pair for thermochemical energy storage by doping with salts
34. Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer
35. Cancer Genetic Markers According to Radiotherapeutic Response in Patients with Glioblastoma - Radiogenomic Approach for Precision Medicine
36. The Effect of Low Dose Radiation on Alzheimer's Disease-Induced TG Mice
37. RET fusions in a small subset of advanced colorectal cancers at risk of being neglected
38. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
39. Frozen embryo transfer instead of fresh embryo transfer can increase pregnancy and implantation rates and reduce biochemical pregnancy in advanced maternal aged women
40. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition
41. Verification of radiation heat transfer analysis in KSTAR PFC and vacuum vessel during baking
42. The clinicopathologic features and treatment of 607 hindgut neuroendocrine tumor (NET) patients at a single institution
43. Programmed death-ligand 1 (PD-L1) and immune infiltrates are prognostic for better outcome and enriched in the ATM (ataxia telangiectasia mutated)-low segment of gastric cancer (GC)
44. 491 Cellular response patterns to single MEK inhibition correlate with the efficacy of combined MEK/CDK4,6 targeting in melanoma
45. P-214 Salvage Chemoradiotherapy for Locally Recurrent Bile Duct Cancer
46. P-106 Anxiety and depression as predictive factors for quality of life in patients with newly diagnosed advanced gastrointestinal cancer
47. 2214 KIAA1324, a novel tumor suppressor in gastric cancer through inhibition of GRP78 oncoprotein
48. 1538 Anxiety and depression in patients with newly diagnosed metastatic gastrointestinal cancer
49. 2318 Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer
50. P-145 Prospective Phase II Trial of Combination Treatment of Whole Hepatic Irradiation and Hyperthermia in Chemorefractory Numerous Hepatic Metastases of Gastrointestinal Malignancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.